ARTICLE | Company News
Leidos, GeoVax to develop immonotherapeutic vaccines
November 30, 2018 4:43 AM UTC
GeoVax Labs Inc. (OTCBB:GOVX) and Leidos Holdings Inc. (NYSE:LDOS) partnered to develop immunotherapeutic vaccines using GeoVax’s Modified Vaccinia Ankara-Virus Like Particles (MVA-VLP) platform and undisclosed PD-1 inhibitors from Leidos...